Publications by authors named "Sunil Shewale"

Claim this Profile
A
A randomized, active-controlled, multi-centric, phase-II clinical study to assess safety and immunogenicity of a fully liquid DTwP-HepB-IPV-Hib hexavalent vaccine (HEXASIIL®) in Indian toddlers.
Hitt Sharma, Sameer Parekh, Pramod Pujari, Sunil Shewale, Shivani Desai

Vaccine· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase III randomized-controlled study of safety and immunogenicity of DTwP-HepB-IPV-Hib vaccine (HEXASIIL) in infants.
Hitt Sharma, Sameer Parekh, Pramod Pujari, Sunil Shewale, Shivani Desai

NPJ Vaccines· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9-14 years versus an established quadrivalent HPV vaccine in women aged 15-26 years in India: a randomised, active-controlled, multicentre, phase 2/3 trial.
Hitt Sharma, Sameer Parekh, Pramod Pujari, Sunil Shewale, Shivani Desai

Lancet Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of SIIPL Tdap, a new tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, in healthy subjects 4-65 years of age: A Phase II/III randomized, observer-blinded, active controlled, multicenter clinical study in Germany.
Inci Aydin, Marcus May, Fabio Pisano, Nontsikelelo Mpofu-Maetzig, Leander Grode, Sunil Shewale

Vaccine· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I study to evaluate safety and tolerability of DTaP-IPV + Hib vaccine in healthy adult volunteers in India.
Hitt Sharma, Kiran Marthak, Sameer Parekh, Pramod Pujari, Sunil Shewale

Vaccine X· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase-I, open label clinical trial to assess the safety & tolerability of qHPV vaccine manufactured by Serum Institute of India Pvt. Ltd. in adults.
Hitt Sharma, K Anil, Sameer Parekh, Pramod Pujari, Sunil Shewale

Vaccine X· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of an indigenously developed tetanus toxoid, diphtheria toxoid, and acellular pertussis vaccine (Tdap) in adults, adolescents, and children in India.
Hitt J Sharma, Sameer Parekh, Pramod Pujari, Sunil Shewale, Shivani Desai

Expert Rev Vaccines· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I, open label, clinical study to assess the safety and immunogenicity of indigenously developed liquid (DTwP-HepB-IPV-Hib) hexavalent combination vaccine in healthy toddlers aged 16-24 months.
Hitt Sharma, Sanjay Lalwani, Sameer Parekh, Pramod Pujari, Sunil Shewale

Hum Vaccin Immunother· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Th1-Th2 Seesaw: An Essential Aspect in Type 1 Diabetes.
Shivani Desai, Ramesh Bhonde, Hitt Sharma, Prajakta Kamble, Jagruti Shimpi, Sunil Shewale

Curr Diabetes Rev· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase-I, open label clinical trial to assess the safety of Tdap vaccine manufactured by Serum Institute of India Pvt. Ltd. in adults.
Hitt Sharma, K Anil, Sameer Parekh, Pramod Pujari, Sunil Shewale

Vaccine· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccines For Type 1 Diabetes: Prevention or Reversal?
Shivani Desai, Shubhangi Buchade, Sohan Chitlange, Hitt Sharma, Dhiraj Bhombe, Sunil Shewale

Curr Diabetes Rev· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective comparative study to assess the efficacy and tolerability of 2 different doses of intravesical bacillus Calmette-Guerin (BCG) in patients with non-muscle-invasive bladder cancer.
Rajeev Sood, Hitt Sharma, Bhuvaneshwari Sharma, Sameer Parekh, Pramod Pujari, Sunil Shewale

Urol Oncol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-marketing surveillance study to assess the safety and tolerability of an Inactivated Poliomyelitis Vaccine in Indian children.
Hitt Sharma, Rajeev Dhere, Sameer Parekh, Sunil Shewale

Hum Vaccin Immunother· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Right atrial spindle cell sarcoma as a rare cause of tricuspid stenosis.
Sunil D Shewale, Prabhavathi Bhat, Anshul Kumar Gupta, Cholenahally Nanjappa Manjunath

BMJ Case Rep· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sero-surveillance to assess rubella susceptibility and assessment of immunogenicity and reactogenicity of rubella vaccine in Indian girls aged 18-24 years.
Deepak S Phalgune, Rajiv C Yervadekar, Hitt J Sharma, Rajeev M Dhere, Sameer S Parekh, Sunil D Shewale

Hum Vaccin Immunother· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody persistence of two pentavalent DTwP-HB-Hib vaccines to the age of 15-18 months, and response to the booster dose of quadrivalent DTwP-Hib vaccine.
Hitt Sharma, Sangeeta Yadav, Sanjay Lalwani, Subhash Kapre, Suresh Jadhav, Sunil Shewale

Vaccine· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of safety and immunogenicity of two different lots of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine manufactured using small and large scale manufacturing process.
Hitt J Sharma, Vishwanath D Patil, Sanjay K Lalwani, Mamta V Manglani, Latha Ravichandran, Sunil D Shewale

Vaccine· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seroprevalence of rubella and immunogenicity following rubella vaccination in adolescent girls in India.
Hitt J Sharma, Vasant S Padbidri, Subhash V Kapre, Suresh S Jadhav, Rajeev M Dhere, Sunil D Shewale

J Infect Dev Ctries· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis